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Abstract. Wet-spinning is a non-solvent induced phase inversion technique that allows the 
production of continuous polymeric microfibers, with a uniform morphology, based on the 
principle of precipitation. It allows the production of 3D fibrous constructs with an intricated 
architecture that facilitates cell infiltration, something that is very limited in electrospun 
nanofibrous mats, thus increasing its interest in biomedicine. Wet-spun scaffolds are also more 
easily processed and can be loaded with a variety of biomolecules of interest. Antimicrobial 
agents that display a broad spectrum of activity against bacteria, fungi and viruses have been 
combined with such constructs demonstrating great potential to fight infections. In the present 
work, we explore the use of wet-spinning to process both natural and synthetic biodegradable 
polymers in the form of microfibers, and the necessary processes to modify their surface to 
increase their antimicrobial profile. The synergistic potential of specialized biomolecules within 
wet-spun fibrous architectures are also highlighted. 
1.  Introduction 
Advances in polymer processing technologies have allowed for new 2D and 3D fibrous constructs to 
occur and be manipulated as required. With these techniques at our disposal, it is now possible to control 
the scaffolds architecture, their interconnected network and overall surface chemistry through the 
incorporation of desirable functional groups. Through those, active biomolecules can be loaded to 
regulate cell behavior or fight microorganisms’ colonization [1].  
Several techniques have been used in the development of such constructs, with a variety of macro-
shapes and micro- and nanostructures, including drawing, melt blown, template synthesis, phase 
separation, self-assembly and spinning methods. The drawing method can produce individual, long 
nanofibers. However, its application is limited to viscoelastic materials capable of tolerating significant 
deformations. Melt blown also requires thermoplastic polymers and adequate air pressure. Using 
template synthesis, solid/hollow, individual nanofibers can be produced. Yet, this too presents 
disadvantages, namely the discontinue nature of the obtained fibers. Phase separation is a time-
consuming technique that comprises stages of dissolution, gelation, solvent extraction, freezing and 
drying, leading to the formation of non-porous foams. Self-assembly is as well a time-consuming 
approach, in which units are arranged in specific configurations to attain particular functions in the final 
product [2, 3]. Polymeric fiber meshes formed of micro and nanofibers produced from spinning 
techniques display high surface area and increased interconnected open pore structure that facilitates 
cell migration and infiltration, nutrients and mass transport, and the controlled release of loaded 
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bioactive agents [1, 4]. Even though the electrospinning technique has been widely pursued in 
biomedicine in current years, the small porosity and high fiber density that characterizes the produced 
mats has been highlighted as a negative aspect by limiting cell infiltration within the innermost regions 
of the scaffolds and/or by being unable to generate dynamic micro-environments that closely resemble 
the natural interstitial fluid conditions in vivo [5]. These features, however, can be achieved using the 
wet-spinning technique (Figure 1) [4, 6]. With wet-spinning it is possible to generate hybrid structures 
with different levels of organization and particular arrays of chemical and physical properties, avoiding 
the problems associated with thermal degradation (melt-spinning) or inability to establish optimal 
processing parameters [2, 7-9]. In this technique continuous micrometric polymeric fibers can be 
extruded towards a non-solvent coagulation bath for filament solidification. Wet-spun fibrous constructs 
can be manufactured with a variety of configurations. The most common are the continuous fiber 
constructs. However, core-shell or hollow fibers are also very common in drug delivery systems. These 
are commonly produced via an air-gap wet-spinning system which uses a two-coaxial-nozzle extrusion 
apparatus in which air flows through the inner nozzle [10]. Wet-spinning has been mostly used in the 
processing of natural origin polymers, including chitosan, starch, collagen and silk fibroin. However, 
their potentialities as drug-loading therapeutic delivery systems or tissue engineering scaffolds have 
extended their uses to other synthetic, biodegradable polymers, namely polycaprolactone (PCL) or poly-
L-lactic acid (PLLA) [11].  
The employment of antimicrobial agents, like antibiotics, proteins, nanoparticles, or even natural 
extracts, in biomedical applications is not new. Indeed, many formulations have been proposed with 
exceptional results. Yet, the contributions of such molecules within the overall properties of wet-spun 
microfibers or 3D constructs for biomedicine are not entirely clear. In the present work, we explore this 
further and provide examples of the most successful applications of these modified systems. Special 
attention will be given to the types of antimicrobial molecules employed in biodegradable constructs 
and their mechanisms of action.   
 
 
Figure 1. Schematic representation of a wet-spinning apparatus. 
2.  Antimicrobial agents: types and properties  
Incorporation of biological cues or biomolecules within the surface or structure of wet-spun fibers has 
been one of the most resorted strategies to broaden the use of biodegradable polymeric fibrous constructs 
in biomedical engineering [1, 6, 12]. Between the available options (antibiotics, proteins, peptides, 
growth factors, natural extracts, etc.), the antibiotics can be highlighted as the most frequently used. 
These chemical compounds have been around since the 20’s with the discovery of penicillin [13]. 
Antibiotics can be obtained from microbial fermentation or be chemically synthesized. They target 
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bacteria via their membrane structure or cell wall organization, or by disrupting the functions of specific 
intracellular components, namely proteins, DNA and RNA, etc [12]. In general, antibiotics represent a 
primary source of treatment for infections. However, the unchecked and misuse of antibiotics has 
increased tolerance and led to the emerging of antibiotic-resistant microorganisms [14]. For that reason, 
alternative biomolecules are now being examined and their synergistic effect with polymeric scaffolds 
are researched. Natural extracts are an important source of drugs in traditional medicine and are growing 
in importance each day due to their reduced impact in the environment and extended therapeutic 
potential. Via their biochemical pathways or secondary metabolites, natural extracts can generate 
specific chemical responses when facing environmental threats. This way being capable of protecting 
the plant by acting as antioxidants, free radical-scavengers, UV-light absorbents and antiproliferative 
agents, which attack microorganisms. The antimicrobial action of natural extracts includes enzyme 
inhibition, non-specific interactions with proteins, intercalation of pathogenic DNA, and interference 
with the cell membrane by forming ion channels or inhibiting the adhesion of microbial proteins. 
Essential oils (EOs), for instance, are volatile compounds that present a strong odor. They exhibit 
antibacterial, antiviral and antifungal properties associated with analgesic, antiseptic, anxiolytic, anti-
inflammatory and antioxidant effects [12, 15, 16]. Proteins, peptides, and growth factors have long been 
proposed as bioactive molecules to induce specific cell functions due to their biocompatible nature, 
presence in the human body, and versatile structure from which self-assembly of biomaterials with 
hierarchical 3D architectures is possible. These are most frequent in tissue engineering to promote an 
implantable biomaterial recognition and to accelerate integration. Presently, in this category, 
antimicrobial peptides (AMPs) are the ones with the most potential to fight infections. AMPs act by 
targeting the lipopolysaccharide layer of pathogens, which is exclusive to them. They exibit a broad 
spectrum of activity, with their mechanisms of action being mostly directed towards the cell membrane 
and/or the intracellular components after membrane penetration [1, 6, 12, 15]. 
3.  Biofunctionalized, biodegradable wet-spun fibers  
Many biodegradable polymers and hybrid structures have been processed by wet-spinning with 
exceptional capacities for drug-delivery systems. Most of those resort to the direct processing of the 
polymer solutions in a coagulation bath containing the bioactive agent or drug to be loaded. Denkbaş et 
al. proposed the production of chitosan microfibers extruded at 0.1 mL/h within a bath containing 
different concentrations of the hydrophilic anticancer drug 5-fluorouracil. The formed chitosan 
filaments were entangled with each other originating scaffolds. Glutaraldehyde was used as cross-
linking to maintain the fibers structure and, this way, guarantee the incorporation of the drug. The facile 
modification method allowed the fibers to release high amounts of the drug in the initial stages of 
interaction (first 90 min) and, then, to guarantee a continuous but slower release rate for prolonged 
periods of time. Depending on the cross-linker density applied to the chitosan fibers, much slower 
release profiles were attained [17]. Yet, there are alternatives in which the biomolecule is incorporated 
within the polymeric matrix before or after extrusion or is encapsulated in a core-shell structure. For 
instance, Gao et al. suggested the addition of 5-fluorouracil to PLLA wet-spun fibers by homogenous 
dispersion within the polymeric blend. The drug was initially crushed by fluid jet mill and then dispersed 
in a chloroform solution containing 1% Span 80 to form a stable suspension. PLLA was then combined 
and the solution continuously stirred until the fibers were extruded at a fixed flow rate and 25 cm 
distance from the spinneret. Drug release kinetics was controlled by optimizing the drug content, 
polymer concentration, non-solvent bath, and extrusion flow rate. Since most of the 5-fluorouracil was 
incorporated within the PLLA fibers, the initial release burst was not toxic to cells, allowing the drug to 
be delivered at smaller doses for longer periods, desired for cancer treatments [18]. In a different study, 
collagen was allowed to self-assemble within a pre-formed chitosan-tripolyphosphate microfiber mesh. 
After microfiber production, a collagen solution was left to self-assemble into nano and microfibers, 
subsequently freeze-dried, in order to generate a multi-size architecture. The engineered biodegradable 
polymeric scaffold revealed exceptional cell activity and cytocompatibility towards fibroblasts and 
osteoblasts, owing the observed attachment and proliferation rates to the presence of the bioactive 
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collagen [19]. Hollow microfibers are mostly attractive for tissue engineering of small caliber blood 
vessels. PCL and PCL/poly(lactide-co-glycolic acid) (PLGA) hollow fibers have been produced via wet-
spinning with excellent mechanical resistance and enhanced capacity to transport substances. Here, a 
spinneret with an outer and inner needle was employed, extruding the polymer solution at a flow rate of 
1 mL/min. Distilled water was used as the bore liquid, which was extruded at 2.4 mL/min, and ethanol 
was used in the coagulation bath. Existing traces of the polymer solvents were then eliminated by placing 
the fibers in a water bath and exchanging the media periodically. Even though the hollow fibers purpose 
was the transport of blood components, the incorporation of bioactive or antimicrobial agents at their 
core was determined possible [20, 21].  
Accounts on antibiotic loading onto wet-spun fibers are very frequent. Puppi et al. reported on the 
functionalization of 3D PCL meshes with the fluoroquinolone antibiotics enrofloxacin, active against 
osteomyelitis pathogens, and levofloxacin, a broad-spectrum antimicrobial biomolecule proven 
effective against infections of the respiratory and genitourinary tract, skin and skin structures, and 
osteomyelitis. Here, the antibiotics were loaded within the polymeric matrix and blended continuously 
until a homogeneous dispersion was attained. Fibers were wet-spun at a control flow rate set at 2.25 
mL/h, through a 0.4 mm inner diameter needle into an ethanol coagulation bath (24 h immersion). 
Loading efficiency was not evidenced as only 18-27% of the drugs were found on the fibers. Regardless, 
the loaded fibers demonstrated a fast-initial burst release, followed by a sustained liberation of the 
antibiotics up to five weeks. Cytocompatibility experiments revealed the formation of a cellular layer 
within the scaffolds after 14 days of culture [5]. To overcome the loading limitations, they proposed a 
computer-aided wet-spinning approach using a three-arm branched PCL that did not require fiber post-
processing. Levofloxacin loading was efficiently controlled to guarantee a prolonged, sustained-release 
without interference in the microfiber’s morphology. The drug was blended with the polymer for 2 h. 
By using a programmable syringe pump, the blend was then injected at a controlled feeding rate directly 
into a coagulation bath of ethanol. Even though encapsulation efficiency remained within equal ranges, 
≈ 16%, near 90% of the total drug release was reached in vitro over a 5-week period without aggressive 
initial bursts [22]. In another strategy, Aksoy et al. resorted to the encapsulation of the antibiotic 
vancomycin within microspheres of gelatin, which were prepared by coacervation technique. Briefly, 
the microspheres were produced by dropwise addition of gelatin containing the vancomycin into corn 
oil and cross-linked with glutaraldehyde. Then, they were added to PCL and mixed for homogeneous 
dispersion before being extruded through a 0.5 mm diameter needle into a 4ºC ethanol coagulation bath 
under continuous stirring. They established that the presence of PCL retarded the released of 
vancomycin from the microspheres, providing a long-term sustained liberation of the drug, with strong 
antimicrobial action against both Staphylococcus aureus and Staphylococcus epidermidis bacteria [23].  
Wet-spun scaffolds of chitosan have been examined for the liberation of both the antibiotic 
gentamicin and the protein bovine serum albumin (BSA). The goal was to engineer a scaffold with a 
double function of support material for defect sites and delivery platform of bioactive molecules. Porous, 
microfibrous scaffolds were produced from chitosan solutions and used as bare or coated with alginate 
to serve as contributing layer to facilitate the loading and release regulation of the protein and the 
antibiotic. Chitosan blend was injected at a speed of 5 mL/h into a bath of Na2SO4 (0.5 M) and left 
immersed overnight for complete fiber formation. Alginate was then coated onto the fibrous scaffolds 
via vacuum-pressure cycling. The biomolecules were loaded via a series of vacuum-pressure cycles or 
blended with the polymers prior to wet-spinning and alginate coating. Data demonstrated the release 
from the scaffold was facilitate by the absence of the alginate layer; however, in the cases where the 
alginate coating was present, a decreased initial burst release of BSA and retarding effect of gentamicin 
was detected. Moreover, release of the agents was controlled via diffusion mechanism, with the size of 
the biomolecules determining their release rate from the scaffold (BSA was slower than gentamicin due 
to its larger molecular weight, Mw) [24]. BSA release kinetics has also been examined on PLLA and 
PLGA wet spun microfibers. Indeed, Lavin et al. using a cryogenic emulsion approach encapsulated 
insulin, lysozyme and BSA within wet-spun fibers of ≈ 100 µm in diameter. Again, protein loading 
influenced the fibers mechanical strength and conditioned the biomolecules release kinetics in a Mw-
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dependent manner. For instance, BSA was found to increase the tensile strength and the elongation at 
break of the PLGA fibers twofold and fourfold above those of BSA-loaded PLLA, respectively. Still, in 
both cases, prolonged protein release, up to 63 days, was observed [25]. These studies emphasized the 
critical role of the molecular weight and chemical structure of the loaded biomolecules within the overall 
performance of the scaffold. Further, they demonstrated their synergistic effect and the ability to produce 
sequential delivery systems based on such combinations. 3D constructs loaded with a sequential growth 
factor release profile have been generated. Fiber meshes were produced from chitosan and from 
chitosan-polyethylene glycol (PEO) by wet-spinning using Na2SO4 (0.5 M), NaOH (1 M) and distilled 
water (3:1:6 v/v) as coagulation bath, in which they were kept overnight, and then combined with 
nanocapsules of PLGA containing the bone morphogenetic protein 2 (BMP-2) and with nanocapsules 
of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) containing BMP-7. Nanocapsules were 
prepared by double emulsion-solvent evaporation technique and were incorporated during production 
by blending with the polymer solutions or after production via surface-modification with a series of 
vacuum-pressure cycles. This combination of polymers allowed the premature release of the BMP-2 and 
the retarded released of the BMP-7. The effect of the delivery agents was more important on the surface-
modified fibers, with the BMP sequential delivery raising the levels of the alkaline phosphatase activity 
per cell. Data reported on the potential of the combinatory effect of polymers and bioactive agents for 
bone tissue engineering [26].  
More recently, as antibiotic-resistant bacteria are becoming a global concern, alternatives for the 
delivery of antimicrobial agents are being engineered. Natural extracts are becoming more attractive for 
their reduced impact in the environment and diverse potential as antimicrobial, antiseptic, analgesic, 
and/or anti-inflammatory agents. In light of this phenomenon, Felgueiras et al. proposed the 
modification of wet-spun microfibers made of cellulose acetate (CA) and PCL with ampicillin (control) 
and three EOs, cinnamon leaf oil, clove oil and cajeput oil. Microfibers were wet-spun towards an 
ethanol-based coagulation bath at a constant speed of 0.5 mL/h. EOs were incorporated within the fibers 
by physical adsorption during a 72 h immersion period at room temperature and constant stirring at 200 
rpm. Acquired data reported the ability of the modified fibers to effect on the viability of Staphylococcus 
aureus and Escherichia coli bacteria, even at small, immobilized concentrations. Further, the EOs-
modified fibers were seen to kill bacteria more quickly and to disrupt the bacteria cytoplasmic membrane 
more easily than the antibiotic, attesting to their potential to replace antibiotics and to be incorporated 
within scaffolding materials for applications in which bacterial infections are a target [27]. Overall, the 
contribution of biodegradable, micro-structured, wet-spun platforms for the delivery of biomolecules of 
interest was confirmed and their potential for biomedical applications demonstrated.   
4.  Conclusions 
The resourcefulness of the wet-spinning technique, in polymer selection, loading methodology and 
biomolecule, and fiber morphology (porosity, shape and size), has led to an increase amount of reports 
on the abilities of biodegradable microfibrous constructs, originated from natural and synthetic resources, 
for biomedical applications. 3D wet-spun architectures with a pre-established external shape and 
macropores internal structure can now be tailored to fit a desirable need. Further, biofunctionalization 
via biomolecule loading has increased their effectiveness in various areas of biomedical research, 
turning these systems very promising, and opening new opportunities to integrate such microfibers and 
scaffolds to currently unexplored areas of tissue engineering.   
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